NCT03017950

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

Phase I Clinical Trial to Evaluate the Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 83 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is examining and comparing the pharmacokinetic drug interaction and safety of both single administration and combination administration of CKD-330 and D086 to healthy male subjects

Detailed description

An open-label, randomized, multiple-dose, 2-sequence, 2-period, 2-treatment, crossover study Part1: Examining how D086 affects pharmacokinetics of CKD-330. Part2: Examining how CKD-330 affects pharmacokinetics of D086.

Conditions

• Hypertension
• Hyperlipidemias

Interventions

Type	Name	Description
DRUG	CKD-330
DRUG	D086
DRUG	CKD-330 + D086

Timeline

• Start date: 2016-12-01
• Primary completion: 2017-03-01
• Completion: 2017-05-01
• First posted: 2017-01-11
• Last updated: 2017-07-21

Locations

1 site across 1 country: South Korea